Actively Recruiting
Hereditary Risk Factors for Thyroid Cancer
Led by Dana-Farber Cancer Institute · Updated on 2025-05-19
250
Participants Needed
1
Research Sites
678 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Thyroid cancers can occur sporadically, but can also be found as tumors that cluster in families with other cancers or genetic syndromes. Researchers are studying thyroid cancer in children and families, with a particular interest in understanding genes and other factors that may put individuals at risk for developing thyroid cancer and thyroid nodules. * In this study, family and medical history information is collected alongside a blood or saliva sample for genetic studies. * Individuals with a past or present childhood thyroid cancer/nodule or a thyroid cancer suspected to be inherited in their family are invited to participate.
CONDITIONS
Official Title
Hereditary Risk Factors for Thyroid Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individual pediatric patient with current or previous known or suspected thyroid cancer or nodule(s).
- Individual adult patient with current or previous known or suspected thyroid cancer or nodule(s) if they come from a family with a high suspicion of hereditary cancer.
- Individuals from families with a high suspicion of hereditary thyroid cancer including:
- Families with a current or previous diagnosis of thyroid cancer or nodule occurring in childhood (under 18 years old).
- Families with thyroid cancer in multiple individuals.
- Families with thyroid cancer and a known genetic syndrome.
- Families with thyroid cancer and a suspected genetic syndrome such as multiple childhood cancers, multiple primary cancers, or multiple endocrinopathies in the family.
You will not qualify if you...
- Individuals who are unable to give informed consent.
- Individuals who are unable to complete study materials.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115
Actively Recruiting
Research Team
J
Junne Kamihara, MD, PhD
CONTACT
S
Sarah Hunt, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here